Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can paying home visiting agencies for extra services help High-Risk moms and babies?

NCT ID NCT07817407

Disease control Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 15, 2026 · Updated 1 time

Summary

Researchers are studying whether giving Michigan home visiting agencies more ways to bill Medicaid for extra services helps them better support families with high needs. The trial compares families served by agencies that receive these extra billing options with families served by agencies that do not. Participants are mothers and infants enrolled in the Maternal Infant Health Program who qualify for Medicaid and are identified as high risk. Researchers will look at health care use, like postpartum visits and well-child visits, and survey participants about their economic stability, housing, and social well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
extra billing options for home visiting agencies, including additional visits, care coordination, and discharge planning
What this could lead to
If it works, this could give home visiting agencies a way to offer more visits and support to families who need it most, possibly improving health care use and social well-being.
What could go wrong
The study tests a billing change, not a new treatment, so any benefits may be modest or limited to certain families. It may not show clear improvements in health or social outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10,927 people

The number who actually took part.

Started

Aug 2021

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Eligible for Medicaid * Identified as "high risk" based on responses to the Maternal Risk Identifier (MRI) or Infant Risk Identifier (IRI), administered upon enrollment. Exclusion Criteria: * Participants under the age of 18.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health care utilization are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Acceptance of Health Care

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health care utilization Social determinants of health (SDOH)

Contacts and locations

Locations

  • Maternal Infant Health Program

    Lansing, Michigan, 48933, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.